Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)-Reference-Cited by-同舟云学术

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)

Published:2010-05 Issue:9 Volume:20 Page:2797-2800
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Boatman P. Douglas,Schrader Thomas O.,Kasem Michelle,Johnson Benjamin R.,Skinner Philip J.,Jung Jae-Kyu,Xu Jerry,Cherrier Martin C.,Webb Peter J.,Semple Graeme,Sage Carleton R.,Knudsen Jens,Chen Ruoping,Taggart Andrew K.,Carballo-Jane Ester,Richman Jeremy G.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference20 articles.

1. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

2. Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease

3. Hypertension

4. Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin

5. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of methyl 5-((cinnamoyloxy)methyl)picolinate, exploring its bio-target potential aiming at CVD mediated by multiple proteins through surface and physiochemical analysis;Scientific Reports;2024-06-10

2. Opportunities for the Application and Advancement of the Corey–Chaykovsky Cyclopropanation;Organic Process Research & Development;2022-12-21

3. Multifaceted Chemistry of Tetrazole. Synthesis, Uses, and Pharmaceutical Applications;Russian Journal of Organic Chemistry;2022-12

4. Novel Niacin Receptor Agonists: A Promising Strategy for the Treatment of Dyslipidemia;Mini-Reviews in Medicinal Chemistry;2021-11-23

5. Applications of fluorine to the construction of bioisosteric elements for the purposes of novel drug discovery;Expert Opinion on Drug Discovery;2021-06-10